參考文獻 |
1. Guo, J. L.; Lee, V. M., Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nature medicine 2014, 20 (2), 130-138.
2. Westergard, T.; Jensen, B. K.; Wen, X.; Cai, J.; Kropf, E.; Iacovitti, L.; Pasinelli, P.; Trotti, D., Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell reports 2016, 17 (3), 645-652.
3. McAlary, L.; Plotkin, S. S.; Yerbury, J. J.; Cashman, N. R., Prion-like propagation of protein misfolding and aggregation in amyotrophic lateral sclerosis. Frontiers in molecular neuroscience 2019, 12, 262.
4. Prasad, A.; Bharathi, V.; Sivalingam, V.; Girdhar, A.; Patel, B. K., Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Frontiers in molecular neuroscience 2019, 12, 25.
5. Takahashi, R. H.; Nagao, T.; Gouras, G. K., Plaque formation and the intraneuronal accumulation of β‐amyloid in Alzheimer′s disease. Pathology international 2017, 67 (4), 185-193.
6. Stefanis, L., α-Synuclein in Parkinson′s disease. Cold Spring Harbor perspectives in medicine 2012, 2 (2), a009399.
7. Mackenzie, I. R.; Rademakers, R.; Neumann, M., TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. The Lancet Neurology 2010, 9 (10), 995-1007.
8. Nonaka, T.; Arai, T.; Buratti, E.; Baralle, F. E.; Akiyama, H.; Hasegawa, M., Phosphorylated and ubiquitinated TDP‐43 pathological inclusions in ALS and FTLD‐U are recapitulated in SH‐SY5Y cells. FEBS letters 2009, 583 (2), 394-400.
9. Sackmann, C.; Sackmann, V.; Hallbeck, M., TDP-43 is efficiently transferred between neuron-like cells in a manner enhanced by preservation of its N-terminus but independent of extracellular vesicles. Frontiers in neuroscience 2020, 14, 540.
10. Wegorzewska, I.; Baloh, R. H., TDP-43-based animal models of neurodegeneration: new insights into ALS pathology and pathophysiology. Neurodegenerative Diseases 2011, 8 (4), 262-274.
11. Guo, W.; Chen, Y.; Zhou, X.; Kar, A.; Ray, P.; Chen, X.; Rao, E. J.; Yang, M.; Ye, H.; Zhu, L., An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nature structural & molecular biology 2011, 18 (7), 822.
12. Fang, Y.-S.; Tsai, K.-J.; Chang, Y.-J.; Kao, P.; Woods, R.; Kuo, P.-H.; Wu, C.-C.; Liao, J.-Y.; Chou, S.-C.; Lin, V., Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nature communications 2014, 5 (1), 1-13.
13. Harischandra, D. S.; Rokad, D.; Neal, M. L.; Ghaisas, S.; Manne, S.; Sarkar, S.; Panicker, N.; Zenitsky, G.; Jin, H.; Lewis, M., Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein. Science signaling 2019, 12 (572).
14. Iguchi, Y.; Eid, L.; Parent, M.; Soucy, G.; Bareil, C.; Riku, Y.; Kawai, K.; Takagi, S.; Yoshida, M.; Katsuno, M., Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 2016, 139 (12), 3187-3201.
15. Menon, A. V.; Chang, J.; Kim, J., Mechanisms of divalent metal toxicity in affective disorders. Toxicology 2016, 339, 58-72.
16. Roos, P. M.; Vesterberg, O.; Syversen, T.; Flaten, T. P.; Nordberg, M., Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biological trace element research 2013, 151 (2), 159-170.
17. Hozumi, I.; Hasegawa, T.; Honda, A.; Ozawa, K.; Hayashi, Y.; Hashimoto, K.; Yamada, M.; Koumura, A.; Sakurai, T.; Kimura, A., Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. Journal of the neurological sciences 2011, 303 (1-2), 95-99.
18. Caragounis, A.; Price, K. A.; Soon, C. P.; Filiz, G.; Masters, C. L.; Li, Q.-X.; Crouch, P. J.; White, A. R., Zinc induces depletion and aggregation of endogenous TDP-43. Free Radical Biology and Medicine 2010, 48 (9), 1152-1161.
19. Garnier, C.; Devred, F.; Byrne, D.; Puppo, R.; Roman, A. Y.; Malesinski, S.; Golovin, A. V.; Lebrun, R.; Ninkina, N. N.; Tsvetkov, P. O., Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates. Scientific reports 2017, 7 (1), 1-10.
20. Toffa, D. H.; Magnerou, M. A.; Kassab, A.; Djibo, F. H.; Sow, A. D., Can magnesium reduce central neurodegeneration in Alzheimer′s disease? Basic evidences and research needs. Neurochemistry international 2019, 126, 195-202.
21. Dang, T.; Lim, N.; Grubman, A.; Li, Q.-X.; Volitakis, I.; White, A. R.; Crouch, P., Increased metal content in the TDP-43A315T transgenic mouse model of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Frontiers in aging neuroscience 2014, 6, 15.
22. Tesauro, M.; Bruschi, M.; Filippini, T.; D′Alfonso, S.; Mazzini, L.; Corrado, L.; Consonni, M.; Vinceti, M.; Fusi, P.; Urani, C., Metal (loid) s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data. Environmental Research 2021, 192, 110292.
23. Ash, P. E.; Dhawan, U.; Boudeau, S.; Lei, S.; Carlomagno, Y.; Knobel, M.; Al Mohanna, L. F.; Boomhower, S. R.; Newland, M. C.; Sherr, D. H., Heavy metal neurotoxicants induce ALS-linked TDP-43 pathology. Toxicological Sciences 2019, 167 (1), 105-115.
24. Turchinovich, A.; Drapkina, O.; Tonevitsky, A., Transcriptome of extracellular vesicles: state-of-the-art. Frontiers in immunology 2019, 10, 202.
25. Jo, M.; Lee, S.; Jeon, Y.-M.; Kim, S.; Kwon, Y.; Kim, H.-J., The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Experimental & Molecular Medicine 2020, 52 (10), 1652-1662.
26. Yang, D.; Zhang, W.; Zhang, H.; Zhang, F.; Chen, L.; Ma, L.; Larcher, L. M.; Chen, S.; Liu, N.; Zhao, Q., Progress, opportunity, and perspective on exosome isolation-efforts for efficient exosome-based theranostics. Theranostics 2020, 10 (8), 3684.
27. Wang, C.; Duan, Y.; Duan, G.; Ma, Z.; Zhang, K.; Deng, X.; Qian, B.; Gu, J.; Wang, Q.; Zhang, S., Stress induces cytoprotective TDP-43 nuclear bodies through lncRNA NEAT1-promoted phase separation. bioRxiv 2019, 802058.
28. Ashford, B. A.; Boche, D.; Cooper‐Knock, J.; Heath, P. R.; Simpson, J. E.; Highley, J. R., Microglia in motor neuron disease. Neuropathology and Applied Neurobiology 2021, 47 (2), 179-197.
29. Salvi, V.; Sozio, F.; Sozzani, S.; Del Prete, A., Role of atypical chemokine receptors in microglial activation and polarization. Frontiers in aging neuroscience 2017, 9, 148.
30. Hessvik, N. P.; Llorente, A., Current knowledge on exosome biogenesis and release. Cellular and Molecular Life Sciences 2018, 75 (2), 193-208.
31. Fändrich, M., Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. Journal of molecular biology 2012, 421 (4-5), 427-440.
32. Thompson, A. G.; Gray, E.; Mäger, I.; Thézénas, M.-L.; Charles, P. D.; Talbot, K.; Fischer, R.; Kessler, B. M.; Wood, M.; Turner, M. R., CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis. Clinical Proteomics 2020, 17 (1), 1-12.
33. Cañas, J. A.; Sastre, B.; Rodrigo-Muñoz, J. M.; Del Pozo, V., Exosomes: a new approach to asthma pathology. Clinica Chimica Acta 2019, 495, 139-147. |